Journal
EXPERT OPINION ON DRUG SAFETY
Volume 13, Issue 12, Pages 1565-1568Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14740338.2014.973848
Keywords
disease-modifying therapies; multiple sclerosis; pregnancy; pregnancy prescriptions
Categories
Ask authors/readers for more resources
Multiple sclerosis (MS) is a major neurologic disorder which preferentially affects young women of childbearing age. In the last two decades, a number of disease-modifying therapies have become available to treat relapsing forms of MS. None of these agents is approved for use in pregnancy. The timing of treatment versus conception, and risk of drug pregnancy exposures, are frequent discussion topics when caring for MS patients. This editorial will try to put into context available data, approaches, controversies and future needs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available